No medication is specifically approved to treat derealization, but several drugs prescribed off-label have helped reduce symptoms in clinical settings. Derealization, the persistent feeling that the world around you is unreal or dreamlike, is most commonly part of depersonalization-derealization disorder (DPDR). Because no single drug has proven effective enough to earn formal approval, treatment typically combines therapy with medications chosen based on your specific symptom profile.
Why No Drug Is Officially Approved
As the Mayo Clinic states plainly, “No medicine has been proven to effectively treat depersonalization-derealization disorder.” That doesn’t mean medications are useless. It means none has performed well enough in large clinical trials to receive regulatory approval specifically for DPDR. The condition is relatively rare in its chronic form, which makes it difficult to run the kind of large-scale studies drug approval requires. What exists instead is a patchwork of smaller studies, case reports, and clinical experience pointing toward several promising options.
Most people with chronic derealization also experience depression, anxiety, or both. Medications prescribed for DPDR often target these co-occurring conditions first, which can indirectly improve the derealization itself. In other cases, drugs are chosen specifically for their effect on the brain circuits thought to drive dissociative symptoms.
SSRIs and Antidepressants
Selective serotonin reuptake inhibitors are the most commonly prescribed starting point. They don’t directly treat derealization in most people, but by reducing the anxiety and depression that fuel dissociative episodes, they can lower the overall symptom burden. For some patients, that relief is significant.
One older antidepressant, clomipramine, has shown more direct promise. In a small double-blind trial of patients with primary DPDR, two out of seven participants experienced meaningful improvement in their derealization symptoms. One responder maintained near-complete remission for over four years on the medication, though her symptoms returned every time doctors tried to lower her dose. The other required continuous high-dose treatment to keep symptoms at bay. Clomipramine tends to cause more side effects than modern antidepressants, and three participants in that same trial dropped out because they couldn’t tolerate it. Still, for people who haven’t responded to other options, it remains a consideration.
It’s worth noting that at least one SSRI, fluoxetine, has been reported to trigger or worsen depersonalization and derealization in some individuals. If your symptoms started or intensified after beginning an antidepressant, that’s important information to share with your prescriber.
Lamotrigine: The Most-Discussed Option
Lamotrigine, an anticonvulsant that modulates the brain’s glutamate signaling, is probably the medication most frequently mentioned in DPDR treatment discussions. It’s typically started at a low dose and increased gradually over several weeks. Early case reports found substantial benefits in all four patients tested, which generated real excitement. A follow-up placebo-controlled study of nine patients, however, found no significant advantage over a sugar pill.
Clinical experience since then has landed somewhere in the middle. Some patients clearly improve on lamotrigine, particularly when it’s combined with an SSRI rather than used alone. The combination seems to work more reliably than either drug by itself. If your clinician suggests lamotrigine, expect a slow ramp-up period. The gradual dosing isn’t optional: increasing too quickly raises the risk of a serious skin reaction.
Opioid-Blocking Medications
One of the more interesting pharmacological leads involves naltrexone, a drug that blocks opioid receptors in the brain. The theory is that derealization may involve excessive activity in the brain’s own opioid system, essentially an overactive “numbing” response. By blocking those receptors, naltrexone may help restore normal emotional processing.
Research on people taking naltrexone for other conditions has found that they tend to report lower dissociation scores compared to those on certain other medications. While this evidence is indirect, it aligns with the biological theory, and some clinicians prescribe low-dose naltrexone off-label for DPDR patients who haven’t responded to antidepressants or lamotrigine.
Brain Stimulation for Resistant Cases
When medications don’t work, repetitive transcranial magnetic stimulation (rTMS) has shown encouraging results in small studies. This non-invasive technique uses magnetic pulses to stimulate specific brain regions. For derealization, researchers have targeted an area called the temporoparietal junction, which plays a key role in how you perceive your body and surroundings.
In one study, half of the 12 patients responded after three weeks of treatment. Those who continued for a total of six weeks saw a 68% improvement in DPDR symptoms. A separate study found a 76% reduction in abnormal body experiences and a 54% reduction in feelings of alienation from the environment after six weeks. These are small studies, and rTMS isn’t widely available for this specific condition, but for people with medication-resistant derealization, it represents a real option to discuss with a specialist.
Substances That Can Make It Worse
Several commonly used substances have been linked to triggering or worsening derealization. Alcohol, caffeine, cannabis, and certain sleep medications (particularly zolpidem) have all appeared in case reports as culprits. One documented case involved a 24-year-old man who developed immediate derealization symptoms after taking zolpidem for insomnia. If you’re experiencing derealization and regularly use any of these substances, reducing or eliminating them is a practical first step that costs nothing and risks nothing.
What Treatment Typically Looks Like
Psychotherapy, particularly cognitive behavioral therapy, remains the primary treatment for DPDR. Medications are usually added when therapy alone isn’t enough, or when depression and anxiety are significant contributors. A typical treatment path might start with an SSRI to address mood symptoms, with lamotrigine added if derealization persists. If those approaches fall short, options like clomipramine, naltrexone, or brain stimulation enter the conversation.
Response timelines vary widely. Some people notice improvement within weeks of starting a medication. Others cycle through several options over months before finding something that helps. The condition can also fluctuate on its own, with symptoms easing during low-stress periods and intensifying under pressure. Tracking your symptoms over time, including what makes them better or worse, gives your treatment team better information to work with.
The honest picture is that medication for derealization is imperfect. No pill reliably eliminates the feeling that the world is behind glass. But the combination of targeted therapy, strategic medication use, and avoiding known triggers gives most people meaningful improvement, even if complete resolution takes time.